About Us Services Careers FAQ Contact Us 0
Home Healthcare IT Irritable Bowel Syndrome Treatment Market Size, Trends and Growth Analysis by 2031
Irritable Bowel Syndrome Treatment Market
Irritable Bowel Syndrome Treatment Market

Irritable Bowel Syndrome Treatment Market Size, Share & Trends Analysis Report By Product (Rifaximin, Eluxadoline, Lubiprostone, Linaclotide, Others), By Type (IBS with Diarrhea (IBS-D), IBS with Constipation (IBS-C), Mixed IBS), By Distribution Channel (Hospitals pharmacies, Drug Stores and Retail Pharmacies, Online pharmacies) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2023-2031

Report Code: SRHI55444DR
Last Updated : Mar 08, 2024
Author : Straits Research
Starting From
USD 1850
Buy Now
File Formats

Market Segmentation

  1. Irritable Bowel Syndrome Treatment Market, By Product (2021-2031)
    1. Rifaximin
    2. Eluxadoline
    3. Lubiprostone
    4. Linaclotide
    5. Others
  2. Irritable Bowel Syndrome Treatment Market, By Type (2021-2031)
    1. IBS with Diarrhea (IBS-D)
    2. IBS with Constipation (IBS-C)
    3. Mixed IBS
  3. Irritable Bowel Syndrome Treatment Market, By Distribution Channel (2021-2031)
    1. Hospitals pharmacies
    2. Drug Stores and Retail Pharmacies
    3. Online pharmacies
    1. North America
      1. North America Irritable Bowel Syndrome Treatment Market, By Product
        1. Rifaximin
          1. Eluxadoline
            1. Lubiprostone
              1. Linaclotide
                1. Others
                2. North America Irritable Bowel Syndrome Treatment Market, By Type
                  1. IBS with Diarrhea (IBS-D)
                    1. IBS with Constipation (IBS-C)
                      1. Mixed IBS
                      2. North America Irritable Bowel Syndrome Treatment Market, By Distribution Channel
                        1. Hospitals pharmacies
                          1. Drug Stores and Retail Pharmacies
                            1. Online pharmacies
                            2. U.S.
                              1. U.S. Irritable Bowel Syndrome Treatment Market, By Product
                                1. Rifaximin
                                  1. Eluxadoline
                                    1. Lubiprostone
                                      1. Linaclotide
                                        1. Others
                                        2. U.S. Irritable Bowel Syndrome Treatment Market, By Type
                                          1. IBS with Diarrhea (IBS-D)
                                            1. IBS with Constipation (IBS-C)
                                              1. Mixed IBS
                                              2. U.S. Irritable Bowel Syndrome Treatment Market, By Distribution Channel
                                                1. Hospitals pharmacies
                                                  1. Drug Stores and Retail Pharmacies
                                                    1. Online pharmacies
                                                  2. Canada
                                                2. Europe
                                                  1. Europe Irritable Bowel Syndrome Treatment Market, By Product
                                                    1. Rifaximin
                                                      1. Eluxadoline
                                                        1. Lubiprostone
                                                          1. Linaclotide
                                                            1. Others
                                                            2. Europe Irritable Bowel Syndrome Treatment Market, By Type
                                                              1. IBS with Diarrhea (IBS-D)
                                                                1. IBS with Constipation (IBS-C)
                                                                  1. Mixed IBS
                                                                  2. Europe Irritable Bowel Syndrome Treatment Market, By Distribution Channel
                                                                    1. Hospitals pharmacies
                                                                      1. Drug Stores and Retail Pharmacies
                                                                        1. Online pharmacies
                                                                        2. U.K.
                                                                          1. U.K. Irritable Bowel Syndrome Treatment Market, By Product
                                                                            1. Rifaximin
                                                                              1. Eluxadoline
                                                                                1. Lubiprostone
                                                                                  1. Linaclotide
                                                                                    1. Others
                                                                                    2. U.K. Irritable Bowel Syndrome Treatment Market, By Type
                                                                                      1. IBS with Diarrhea (IBS-D)
                                                                                        1. IBS with Constipation (IBS-C)
                                                                                          1. Mixed IBS
                                                                                          2. U.K. Irritable Bowel Syndrome Treatment Market, By Distribution Channel
                                                                                            1. Hospitals pharmacies
                                                                                              1. Drug Stores and Retail Pharmacies
                                                                                                1. Online pharmacies
                                                                                              2. Germany
                                                                                              3. France
                                                                                              4. Spain
                                                                                              5. Italy
                                                                                              6. Russia
                                                                                              7. Nordic
                                                                                              8. Benelux
                                                                                              9. Rest of Europe
                                                                                            2. APAC
                                                                                              1. APAC Irritable Bowel Syndrome Treatment Market, By Product
                                                                                                1. Rifaximin
                                                                                                  1. Eluxadoline
                                                                                                    1. Lubiprostone
                                                                                                      1. Linaclotide
                                                                                                        1. Others
                                                                                                        2. APAC Irritable Bowel Syndrome Treatment Market, By Type
                                                                                                          1. IBS with Diarrhea (IBS-D)
                                                                                                            1. IBS with Constipation (IBS-C)
                                                                                                              1. Mixed IBS
                                                                                                              2. APAC Irritable Bowel Syndrome Treatment Market, By Distribution Channel
                                                                                                                1. Hospitals pharmacies
                                                                                                                  1. Drug Stores and Retail Pharmacies
                                                                                                                    1. Online pharmacies
                                                                                                                    2. China
                                                                                                                      1. China Irritable Bowel Syndrome Treatment Market, By Product
                                                                                                                        1. Rifaximin
                                                                                                                          1. Eluxadoline
                                                                                                                            1. Lubiprostone
                                                                                                                              1. Linaclotide
                                                                                                                                1. Others
                                                                                                                                2. China Irritable Bowel Syndrome Treatment Market, By Type
                                                                                                                                  1. IBS with Diarrhea (IBS-D)
                                                                                                                                    1. IBS with Constipation (IBS-C)
                                                                                                                                      1. Mixed IBS
                                                                                                                                      2. China Irritable Bowel Syndrome Treatment Market, By Distribution Channel
                                                                                                                                        1. Hospitals pharmacies
                                                                                                                                          1. Drug Stores and Retail Pharmacies
                                                                                                                                            1. Online pharmacies
                                                                                                                                          2. Korea
                                                                                                                                          3. Japan
                                                                                                                                          4. India
                                                                                                                                          5. Australia
                                                                                                                                          6. Singapore
                                                                                                                                          7. Taiwan
                                                                                                                                          8. South East Asia
                                                                                                                                          9. Rest of Asia-Pacific
                                                                                                                                        2. Middle East and Africa
                                                                                                                                          1. Middle East and Africa Irritable Bowel Syndrome Treatment Market, By Product
                                                                                                                                            1. Rifaximin
                                                                                                                                              1. Eluxadoline
                                                                                                                                                1. Lubiprostone
                                                                                                                                                  1. Linaclotide
                                                                                                                                                    1. Others
                                                                                                                                                    2. Middle East and Africa Irritable Bowel Syndrome Treatment Market, By Type
                                                                                                                                                      1. IBS with Diarrhea (IBS-D)
                                                                                                                                                        1. IBS with Constipation (IBS-C)
                                                                                                                                                          1. Mixed IBS
                                                                                                                                                          2. Middle East and Africa Irritable Bowel Syndrome Treatment Market, By Distribution Channel
                                                                                                                                                            1. Hospitals pharmacies
                                                                                                                                                              1. Drug Stores and Retail Pharmacies
                                                                                                                                                                1. Online pharmacies
                                                                                                                                                                2. UAE
                                                                                                                                                                  1. UAE Irritable Bowel Syndrome Treatment Market, By Product
                                                                                                                                                                    1. Rifaximin
                                                                                                                                                                      1. Eluxadoline
                                                                                                                                                                        1. Lubiprostone
                                                                                                                                                                          1. Linaclotide
                                                                                                                                                                            1. Others
                                                                                                                                                                            2. UAE Irritable Bowel Syndrome Treatment Market, By Type
                                                                                                                                                                              1. IBS with Diarrhea (IBS-D)
                                                                                                                                                                                1. IBS with Constipation (IBS-C)
                                                                                                                                                                                  1. Mixed IBS
                                                                                                                                                                                  2. UAE Irritable Bowel Syndrome Treatment Market, By Distribution Channel
                                                                                                                                                                                    1. Hospitals pharmacies
                                                                                                                                                                                      1. Drug Stores and Retail Pharmacies
                                                                                                                                                                                        1. Online pharmacies
                                                                                                                                                                                      2. Turkey
                                                                                                                                                                                      3. Saudi Arabia
                                                                                                                                                                                      4. South Africa
                                                                                                                                                                                      5. Egypt
                                                                                                                                                                                      6. Nigeria
                                                                                                                                                                                      7. Rest of MEA
                                                                                                                                                                                    2. LATAM
                                                                                                                                                                                      1. LATAM Irritable Bowel Syndrome Treatment Market, By Product
                                                                                                                                                                                        1. Rifaximin
                                                                                                                                                                                          1. Eluxadoline
                                                                                                                                                                                            1. Lubiprostone
                                                                                                                                                                                              1. Linaclotide
                                                                                                                                                                                                1. Others
                                                                                                                                                                                                2. LATAM Irritable Bowel Syndrome Treatment Market, By Type
                                                                                                                                                                                                  1. IBS with Diarrhea (IBS-D)
                                                                                                                                                                                                    1. IBS with Constipation (IBS-C)
                                                                                                                                                                                                      1. Mixed IBS
                                                                                                                                                                                                      2. LATAM Irritable Bowel Syndrome Treatment Market, By Distribution Channel
                                                                                                                                                                                                        1. Hospitals pharmacies
                                                                                                                                                                                                          1. Drug Stores and Retail Pharmacies
                                                                                                                                                                                                            1. Online pharmacies
                                                                                                                                                                                                            2. Brazil
                                                                                                                                                                                                              1. Brazil Irritable Bowel Syndrome Treatment Market, By Product
                                                                                                                                                                                                                1. Rifaximin
                                                                                                                                                                                                                  1. Eluxadoline
                                                                                                                                                                                                                    1. Lubiprostone
                                                                                                                                                                                                                      1. Linaclotide
                                                                                                                                                                                                                        1. Others
                                                                                                                                                                                                                        2. Brazil Irritable Bowel Syndrome Treatment Market, By Type
                                                                                                                                                                                                                          1. IBS with Diarrhea (IBS-D)
                                                                                                                                                                                                                            1. IBS with Constipation (IBS-C)
                                                                                                                                                                                                                              1. Mixed IBS
                                                                                                                                                                                                                              2. Brazil Irritable Bowel Syndrome Treatment Market, By Distribution Channel
                                                                                                                                                                                                                                1. Hospitals pharmacies
                                                                                                                                                                                                                                  1. Drug Stores and Retail Pharmacies
                                                                                                                                                                                                                                    1. Online pharmacies
                                                                                                                                                                                                                                  2. Mexico
                                                                                                                                                                                                                                  3. Argentina
                                                                                                                                                                                                                                  4. Chile
                                                                                                                                                                                                                                  5. Colombia
                                                                                                                                                                                                                                  6. Rest of LATAM

                                                                                                                                                                                                                              Related Reports

                                                                                                                                                                                                                              Global Report
                                                                                                                                                                                                                              The global dry eye syndrome treatment market size was valued at USD 4.70 billion in 2022. It is projected to reach USD 7.83 billion by 2031, growing at a CAGR of 5.84% during the forecast period (2023–2031). Factors such as upgrading healthcare
                                                                                                                                                                                                                              Buy Now

                                                                                                                                                                                                                              Purchase Benefits

                                                                                                                                                                                                                              • Eligible for a free updated report next year
                                                                                                                                                                                                                              • Completely customizable scope
                                                                                                                                                                                                                              • 30% discount on your next purchase
                                                                                                                                                                                                                              • Dedicated account manager
                                                                                                                                                                                                                              • Query resolution within 24 hours
                                                                                                                                                                                                                              • Permission to print the report

                                                                                                                                                                                                                              We are featured on :

                                                                                                                                                                                                                              www.straitsresearch.com
                                                                                                                                                                                                                              © Copyright . All rights Reserved.